Related Experiment Video
Updated: Aug 12, 2026
10:26
Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
Eosinophils in a tri-cell multicellular tumor spheroid (MTS)/endothelium complex
P M Furbert-Harris1, K A Hunter, T R Vaughn
1Department of Microbiology, Howard University College of Medicine, Washington, DC 20060, USA. pfurbert-harris@howard.edu
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|December 20, 2003
Summary
Eosinophils can destroy breast cancer cells in a new 3D model. This research clarifies the role of eosinophils in cancer, showing they can be therapeutic agents against tumors.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Eosinophils are present in various cancers, but their role (harmful or helpful) is unclear.
- Their precise function in the tumor microenvironment remains to be elucidated.
Purpose of the Study:
- To develop and utilize an in vitro tri-cell model to investigate eosinophil interactions with breast tumor cells and endothelial cells.
- To determine the impact of eosinophils on tumor cell binding, growth, and destruction.
Main Methods:
- An in vitro tri-cell model was established using eosinophils, MCF-7 breast tumor spheroids, and HUVEC endothelial cells.
- Eosinophil binding, degranulation, and effects on tumor cells were analyzed.
- Interleukin-5 (IL-5) was used to modulate eosinophil activity.
Main Results:
- Eosinophils rapidly and tightly bound to tumor spheroids.
- IL-5 treatment led to tumor cell destruction, especially on endothelial cells.
- Pre-treated eosinophils aggressively bound to endothelial cells, inhibiting tumor attachment.
Conclusions:
- The tri-cell model effectively mimics in vivo observations of eosinophil-tumor interactions.
- Eosinophils demonstrate potential as therapeutic agents in cancer treatment.
- This model facilitates studies on eosinophil-mediated tumor killing mechanisms and therapeutic interventions.
